Auto Summaries

Last updated: 2025 Apr 18

Total hit(s): 21635

S.No.
1	40104250	A Canadian multi-province study of COVID-19 vaccine coverage along area-level social determinants in 2021.	N/A	Public Health Pract (Oxf)	2025 Jun	3.4	1
2	40173425	Erratum: Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness.	N/A	Epidemiology	2025 May 1	4.65	1
3	40203252	Sexually Transmitted Infection Cases During COVID-19: Implications for Public Health.	N/A	Am J Public Health	2025 May	4.21	1
4	40183376	A plain language summary of the available safety data for the BNT162b2 COVID-19 vaccine: development, approval, and surveillance of use.	N/A	Expert Rev Vaccines	2025 Apr 4	4.37	1
5	40122247	Rapid spread of Candida auris in China after COVID-19.	N/A	J Infect	2025 Apr	5.1	1
6	40159907	SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM.	N/A	Epidemiol Infect	2025 Mar 31	2.01	1
7	40155384	Author Correction: Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic.	N/A	NPJ Vaccines	2025 Mar 28	4.98	1
8	40155913	Correction to: Epidemiology, ventilation management and outcomes of COVID-19 ARDS patients versus patients with ARDS due to pneumonia in the Pre-COVID era.	N/A	Respir Res	2025 Mar 28	3.89	1
9	40090768	Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.	N/A	Epidemiol Infect	2025 Mar 17	2.01	1
10	40082077	Data for Action - Description of the Automated COVID-19 Surveillance System in Denmark and Lessons Learnt, January 2020 to June 2024.	N/A	Epidemiol Infect	2025 Mar 14	2.01	1
11	40080318	Correction to: Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID19 reference center.	N/A	Int Microbiol	2025 Mar 13		1
12	39773909	Re: Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness.	N/A	Epidemiology	2025 Mar 1	4.65	1
13	40040473	Shifts in Respiratory Virus Epidemiology on Reunion Island From 2017 to 2023: Impact of COVID-19 Pandemic and Non-Pharmaceutical Interventions.	N/A	Influenza Other Respir Viruses	2025 Mar	3.06	1
14	39923781	Aerosol transmission risk of mpox relative to COVID-19 and smallpox.	N/A	Lancet Microbe	2025 Feb 6	- n/a -	1
15	39923779	Wastewater surveillance for early warning of COVID-19 outbreaks in long-term care facilities.	N/A	Lancet Microbe	2025 Feb 6	- n/a -	1
16	39919777	KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2.	N/A	Lancet Infect Dis	2025 Feb 4	21.77	1
17	39961120	Post-COVID-19 Epidemiology of Bronchiolitis: We Are (Not) Returning to the Past.	N/A	Pediatr Infect Dis J	2025 Feb 14	2.17	1
18	39954314	Exploring mortality representation and the impact of COVID-19 in Modena: insights from "An ECG-based machine-learning approach for mortality risk assessment in a large European population".	N/A	J Electrocardiol	2025 Feb 10	1.2	1
19	39582806	Global epidemiology of telogen effluvium after the COVID-19 pandemic: A systematic review and modeling study.	N/A	JAAD Int	2025 Feb	- n/a -	1
20	40171102	Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance.	N/A	Western Pac Surveill Response J	2025 Jan-Mar		1
21	39757926	Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe.	N/A	Epidemiol Infect	2025 Jan 6	2.01	1
22	39757758	Real-World Impact of COVID-19 on Subcutaneous Immunotherapy Persistence and Efficacy in Allergic Rhinitis.	N/A	Allergy	2025 Jan 5	8.7	1
23	39755838	Correction: Molecular epidemiology and risk analysis for asymptomatic infection with feline enteric coronavirus in domestic and stray cats in Japan.	N/A	Arch Virol	2025 Jan 4	2.23	1
24	39888843	Is a hybrid skin cancer surveillance service for organ transplant recipients feasible?: Lessons from the COVID-19 pandemic.	N/A	Clin Exp Dermatol	2025 Jan 31	1.53	1
25	39884145	A prospective design is required to calculate the epidemiological parameters of patients with SARS-CoV-2-vaccination associated GBS.	N/A	Clin Neurol Neurosurg	2025 Jan 26	1.7	1